CS

1 The products/features are not commercially available in all countries. Due to regulatory reasons, their future availability cannot be guaranteed.

2 The products/features/applications mentioned here are not commercially available in all countries and are subject to local regulations. Their future availability cannot be guaranteed. Not available for sale in the U.S.

3 Throughput values were determined by the time to first result; processing capability varies depending on the reagent used. Throughput values stated above were determined using Siemens Healthineers study protocol with PT (Thromborel® S Reagent) and APTT (Pathromtin® SL Reagent) test applications.

4 Based on internal validation data from Sysmex Corporation.

5 HYPHEN BioMed application. The products/features are not commercially available in all countries. Due to regulatory reasons, their future availability cannot be guaranteed. Please contact your local Siemens Healthineers organization for further details. In the U.S., platelet aggregation testing is for research use only, not for use in diagnostic procedures.

6 Excludes CA-620/660 Systems cuvettes.

7 Throughput values were determined by the time to first result; processing capability varies depending on the reagent used. Throughput values stated above were determined using Siemens’ study protocol with PT (Thromborel® S Reagent), APTT (Pathromtin® SL Reagent), INNOVANCE® D-Dimer Reagent, and AT (INNOVANCE AT Reagent) test applications.

Aptio, Atellica, INNOVANCE, Pathromtin, PSI, Thromborel, and all associated marks are trademarks of Siemens Healthcare Diagnostics Inc., or its affiliates. All other trademarks and brands are the property of their respective owners.

Aptio Automation is manufactured by Inpeco SA and is exclusively distributed by Siemens Healthcare Diagnostics Inc.

The products/features (mentioned herein) are not commercially available in all countries. Due to regulatory reasons their future availability cannot be guaranteed. Please contact your local Siemens organization for further details.